According to a new analysis by Empire Center health policy director Bill Hammond, a $ 1.1 billion -
dollar state program to reimburse hospital charity care is shortchanging hospitals that serve poorer patient to the benefit of those that serve more affluent populations.
Not exact matches
The United
States could lose up to 700,000 jobs and suffer billions of
dollars in lost economic output if President Donald Trump ends a
program granting work permits to the children of undocumented immigrants, a new report finds.
«This calculated theft reportedly netted Otto employees over half a billion
dollars and allowed Uber to revive a stalled
program, all at Waymo's expense,» the lawsuit
states.
Over the past 30 years, policymakers from around the United
States have spent countless hours and numerous
dollars on
programs, policies, and incentives to create venture - capital clusters and to stimulate investments in their cities and regions.
Robotics labs today are filled with million -
dollar,
state - of - the - art robots that struggle with mundane chores, such as gripping a cup of coffee or opening a door, even after months of
programming.
Adding to the pressure on
Dollar General were cuts in food - stamp
programs as seven
states, all governed by Republicans, ended benefits earlier than they had to.
Apple also boosted its capital return
program by $ 100 billion, with repurchases from the increase set to begin in the June quarter, and said it bought $ 23.5 billion of stock back in the March quarter, a sign that it is bringing back most of its hundreds of billions of
dollars in cash to the United
States.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for
state AIDS Drug Assistance
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and
state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase
program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S.
dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Revenue from California's Mental Health Services Act has funded billions of
dollars in mental health
programs across the
state, but finding out what's available — and to whom — could be a challenge for consumers.
When a board of directors authorizes a share repurchase
program, it typically
states either the number of shares the company is interested in buying back or a
dollar amount it will spend on its stock buyback.
But as cities, counties and
states compete for economic development, spending on such
programs nationwide has climbed into the billions of
dollars, even in an era of fiscal austerity.
A robot can never work with an individual to translate someone's
stated needs and wants into a
dollar amount that will accomplish that financial plan and create such a
program to get there.
At the federal level, the Department of Education can implement STEM as a requirement in America's classrooms, and fund more initiatives like Race to the Top, a $ 4 billion
dollar program that to incentivizes
states to develop next - generation educational standards.
All welfare - type
programs are administered by the
States today (social security being the exception) and are funded with a mix of
State and Federal
dollars.
I understand with arresting the pedophile Sandusky, the man should be castrated, but to fire a man who made Penn
State relevant and gave the university its prestige, not forgetting the millions of
dollars made through the football
program, is absurd.
While I agree that we need separation of church and
state... It is a stretch to say that our politicians are establishing a theocracy... on the other hand, you are turning a bling eye to the billions of
dollars that have gone into hospitals, universities, feed the hunger
programs... All funded by people of faith.
Overseen by the Division of Family and Children of the
state's Family and Social Services Administration, FaithWorks provides assistance to faith - based organizations in applying for
state and federal grant
dollars to support new or existing
programs geared to helping people attain self - sufficiency.
The fact that poverty remains a serious problem in the United
States after the federal government has spent $ 22 trillion
dollars on social welfare
programs over the past fifty years should have taught us all something about the complex problems of empowering the poor.
Under the California provisions, for example, the
state supreme court invalidated a
program providing fourteen
dollars» worth of purely secular books for the use of children enrolled in religious schools.
According to one estimate, only 6 percent of public early - childhood education and child - care
dollars in the United
States go to
programs for children who have not yet reached their third birthday.
No
state or federal child safety - net
program allocates
dollars specifically for the purchase of diapers.
Though there is a nearly two - year - old
state mandate that opens the free summer lunch
program to all children in Illinois — whether or not they're in summer school — there has not been much improvement in participation, and officials say millions of federal
dollars available for the meals are going untapped.
Last week, an additional million -
dollar grant was awarded to Mass Audubon, in partnership with the
state Department of Conservation and Recreation, from the U.S. Fish and Wildlife Service's National Coastal Wetlands Conservation
Program.
Although
programs have proliferated to address the needs of fathers and families, there is also a need to evaluate their effectiveness in helping fathers become better parents and better partners.8 Federal and
state policy makers have placed increasing demands on
programs to evaluate the effects these
programs have on fathers and families and whether they are worth investing public
dollars.9
The Partners have successfully worked in 7
states, granting over 2 million
dollars to over 20 school districts to expand breakfast in the classroom
programs in almost 100 schools.
At 3:15 p.m., Sen. Jose Peralta, Assemblywoman Deborah Glick, NYC DOT Commissioner Polly Trottenberg and advocates discuss legislation aimed at expanding the speed camera
program in school zones in New York City, Million
Dollar Staircase, 3rd Floor,
state Capitol, Albany.
One could also attach a special surcharge to copyright enforcement actions in federal court - many
state courts finance a variety of low
dollar programs that way.
At issue were comments O'Luck made on the Times» City Room blog in February 2009, in which he said that if government
programs that benefit businesses owned by women and minorities weren't around «white men and the connected would have access to nearly 100 % of all city,
state, and federal government
dollars spent.»
Assemblyman renews call for creation of a CHIPS - like
state program for towns & cities to protect water, sewer, storm water infrastructure & save tax
dollars
Previous ads cite Faso's record of results as an innovative leader, notably his efforts to enact balanced
state budgets, push for a property tax cap and his role in creating New York's STAR
program, which saves taxpayers millions of
dollars each year.
SYRACUSE, N.Y. - New York
state shut down its out - of - control Empire Zone business incentive
program in 2010 after providing millions of
dollars to companies that
state officials never intended to help.
Assemblyman Jim Tedisco (R,C,I - Glenville) today says two water main breaks in Rotterdam and a sewer break in Amsterdam underscore the continued urgent need for a new
state program to repair and maintain vital local drinking water, sewer, storm water management and gas line infrastructure to protect lives, secure the viability of roads and bridges aboveground, and save tax
dollars.
Governor Cuomo released a
state budget plan that closes a $ 2 billion
dollar gap, recommends a phased in
state takeover of county health care costs, and offers an ultimatum to schools to accept a teacher evaluation
program or lose access to increased school funding.
Trump on Wednesday blasted the tens of millions in taxpayer
dollars that New York
state has spent on the governor's Start Up NY Jobs
program.
Governor Cuomo released a
state budget plan that closes a $ 2 billion
dollar gap, recommends a phased in
state takeover of county health care costs, and offers an ultimatum to schools to accept a teacher evaluation
program or lose increased school funding.
New York's multi-billion
dollar Medicaid
program is paid for by
state, county and federal taxes.
Republicans in the
State Assembly say they are frustrated that there's been no increased oversight in the state's billions of dollars in economic development contracts, including the governor's signature programs like the Buffalo Bil
State Assembly say they are frustrated that there's been no increased oversight in the
state's billions of dollars in economic development contracts, including the governor's signature programs like the Buffalo Bil
state's billions of
dollars in economic development contracts, including the governor's signature
programs like the Buffalo Billion.
The Cuomo administration says the
program actually saves money for the
state by leveraging federal aid for certain noncitizens whose care is now fully paid for with
state dollars.
Many schools plan to add new student
programs and services next year, aided by millions of
dollars in fresh financial assistance from Albany, as well as reductions in
state pension costs.
Kink says he does like the governors» job creation
programs - the biggest one would use over one and half billion
state dollars to leverage billions more in investments for road and bridge and other infrastructure repairs, including a new Tappan Zee Bridge, better flood control, and renewable energy systems.
Replicating the success of the CHIPS
program on the
state level to allow local governments to S.W.A.P. - out deteriorating drinking water, storm water, gas lines and sanitary sewer infrastructure makes sense because an ounce of prevention now can save tax
dollars later and prevent costly breaks.»
And last week, the leader of Ontario vowed to push a law that could restrict New York companies from bidding on billions of
dollars of government contracts in that Canadian province in retaliation for a «Buy American»
program signed two months ago by Gov. Andrew Cuomo for major
state road and bridge projects.
State and county leaders, meanwhile, have poured millions of
dollars into social services and gang - intervention
programs aimed at eliminating MS - 13's most important asset, its recruits.
Assemblyman Jim Tedisco (R,C,I - Glenville), Assemblyman Steve McLaughlin (R,C,I - Schaghticoke) and Assemblyman Phil Palmesano (R,C,I - Corning) are joining with several local Capital Region officials in seeking a new
state program to repair and maintain vital local drinking water, sewer, storm water management and gas line infrastructure to protect lives, secure the viability of roads and bridges aboveground and save tax
dollars.
In
states like California, one of eight where recreational marijuana is legal, hundreds of millions of
dollars in revenue have been raised for school construction and health
programs.
The House passed a measure in a 230 - 188 vote that would reverse a last - minute rule from the Obama administration that said conservative
states can't block the women's health and abortion provider from receiving family planning
dollars under the Title X
program.
The audit showed continued spending on advertising did not lead to an increase in the number of companies who applied for the
program, and the
state continued spending millions of
dollars on advertising even as monthly applications dropped off from roughly 5,300 in January 2014 to about 500 in June of 2014.
«In 2006, the Erie County legislature passed what is called the New York
State Certified Training
Program, which is often known as the apprenticeship law... It ensures taxpayer
dollars that are paying for construction jobs associated with Erie County government are going towards Erie County residents who are working on these projects.
But, Onondaga County Executive Joanie Mahoney says every single
dollar Onondaga County receives from property taxes goes to the
state, due to a series of
programs for which counties are required to pay the
state.
ALBANY —
State comptroller Tom DiNapoli criticized the state's decision to spend hundreds of millions of dollars on advertising to promote Governor Andrew Cuomo's signature economic development programs, including the fledgling Start - Up NY, in an audit released on Mo
State comptroller Tom DiNapoli criticized the
state's decision to spend hundreds of millions of dollars on advertising to promote Governor Andrew Cuomo's signature economic development programs, including the fledgling Start - Up NY, in an audit released on Mo
state's decision to spend hundreds of millions of
dollars on advertising to promote Governor Andrew Cuomo's signature economic development
programs, including the fledgling Start - Up NY, in an audit released on Monday.